Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers

Sakr WA(1994)High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: an autopsy study of 249 cases In Vivo 8 439-443

Zlotta AR(2013)Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men J Natl Cancer Inst 105 1050-1058

Hanahan D(2011)Hallmarks of cancer: the next generation Cell 144 646-674

Weinberg RA(2012)Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? Lancet Oncol 13 e509-e517

Ahmed HU(2012)Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes? Am J Surg Pathol 36 1346-1352

Ross HM(2011)Predicting 15-year prostate cancer specific mortality after radical prostatectomy J Urol 185 869-875

Eggener SE(2012)Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort Br J Cancer 106 1095-1099

Cuzick J(2010)Accurate prediction of repeat prostate biopsy outcomes by a mitochondrial DNA deletion assay Prostate Cancer Prostatic Dis 13 126-131

Robinson K(1992)Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies J Urol 148 829-832

Terris MK(2011)A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial J Urol 185 121-125

Sakr WA(1994)High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: an autopsy study of 249 cases In Vivo 8 439-443

Zlotta AR(2013)Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men J Natl Cancer Inst 105 1050-1058

Hanahan D(2011)Hallmarks of cancer: the next generation Cell 144 646-674

Weinberg RA(2012)Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? Lancet Oncol 13 e509-e517

Ahmed HU(2012)Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes? Am J Surg Pathol 36 1346-1352

Ross HM(2011)Predicting 15-year prostate cancer specific mortality after radical prostatectomy J Urol 185 869-875

Eggener SE(2012)Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort Br J Cancer 106 1095-1099

Cuzick J(2010)Accurate prediction of repeat prostate biopsy outcomes by a mitochondrial DNA deletion assay Prostate Cancer Prostatic Dis 13 126-131

Robinson K(1992)Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies J Urol 148 829-832

Terris MK(2011)A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial J Urol 185 121-125